Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately
Globe Newswire•30/09/2026•08:37 ET
0
Key Highlights
- ➤Hims & Hers (HIMS) shares fell $4.32, or 14.73%, to $25.00 on July 29, 2026
- ➤FTC, California and Utah sued Hims & Hers on July 29, 2026
- ➤Complaint alleges Hims shared consumers' health information with third-party advertising platforms
- ➤Complaint alleges consumers were charged for prescriptions almost immediately after intake submissions
- ➤Lead-plaintiff deadline is November 2, 2026
NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 22025,and July 29, 2026 (the "Class Period").
Investors who purchased Hims & Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026.
Get started
Create a free account to read the full story.